Lu Jie | Investigative Treatment Division National Cancer Center Research Institute East
スポンサーリンク
概要
- LU Jieの詳細を見る
- 同名の論文著者
- Investigative Treatment Division National Cancer Center Research Institute Eastの論文著者
関連著者
-
Esumi Hiroyasu
Investigative Treatment Division, National Cancer Center Research Institute East
-
Lu Jie
Investigative Treatment Division National Cancer Center Research Institute East
-
Esumi Hiroyasu
Invest. Treat. Div. Natl. Cancer Res. Inst.
-
KAMINISHI Michio
Department of Gastrointestinal Surgery, The University of Tokyo, Graduate School of Medicine
-
Kondo S
Institute Of Microbial Chemistry
-
HANAOKA Tomoyuki
Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National
-
KUNIMOTO Setsuko
Institute of Microbial Chemistry
-
Yamazaki Yohko
微生物化学研究会微生物化学研究センター沼津創薬医科学研究所
-
KUNIMOTO Setsuko
Numazu Bio-Medical Research Institute, Microbial Chemistry Research Center
-
Hanaoka Tomoyuki
Epidemiology And Biostatistics Division National Cancer Center Research Institute East
-
Esumi Hiroyasu
Investigative Treatment National Cancer Center Research Institute East
-
Kaminishi Michio
Department Of Breast And Endocrine Surgery Faculty Of Medicine The University Of Tokyo
-
Kaminishi Michio
Department Of Gastrointestinal Surgery University Of Tokyo
-
Lu J
National Cancer Center Res. Inst. East Chiba
-
YAMAZAKI Yohko
Institute of Microbial Chemistry
-
KURASHIMA Yukiko
Investigative Treatment Division, National Cancer Center Research Institute East
-
Kunimoto S
Numazu Bio-medical Research Institute Microbial Chemistry Research Center
-
Kurashima Yukiko
Investigative Treatment Division National Cancer Center Research Institute East
-
山嵜 行由
School Of Pharmaceutical Sciences University Of Shizuoka
-
KURASHIMA Yukiko
Invest. Treat. Div., Natl. Cancer Res. Inst.
-
Hanaoka Tomoyuki
Epidemiology and Biostatistics Division, National Cancer Center Research Institute East
著作論文
- Kigamicin D, a novel anticancer agent based on a new anti-austerity strategy targeting cancer cells' tolerance to nutrient starvation
- Antitumor activity of pyrvinium pamoate, 6-(dimethylamino)-2-[2-(2, 5-dimethyl-1-phenyl-1H-pyrrol-3-yl)ethenyl]-1-methyl-quinolinium pamoate salt, showing preferential cytotoxicity during glucose starvation